Koppy Susan 4
4 · Transcept Pharmaceuticals Inc · Filed Feb 3, 2009
Insider Transaction Report
Form 4
Koppy Susan
VP, Corporate Development
Transactions
- Award
Employee stock option (right to buy)
2009-01-30+61,481→ 61,481 totalExercise: $7.92Exp: 2018-08-25→ Common Stock (61,481 underlying)
Footnotes (2)
- [F1]One-fourth of the shares subject to the option vest on June 12, 2009 and one forty-eighth of the shares shall vest monthly thereafter.
- [F2]Pursuant to the Agreement and Plan of Merger by and among Novacea, Inc. ("Novacea"), Pivot Acquisition, Inc. and Transcept Pharmaceuticals, Inc. ("Transcept"), dated as of August 29, 2008 (the "Merger Agreement"), each outstanding and unexercised option to purchase shares of Transcept common stock outstanding and unexercised was assumed by Novacea and became an option to purchase that number of shares of Novacea common stock equal to the number of shares of Transcept common stock subject to the option multiplied by 0.141340. After completion of the merger, Novacea was renamed Transcept Pharmaceuticals, Inc. and began to trade under the stock symbol TSPT.